Medroxyprogesterone acetate (Depo-Provera) use in adolescents: Uterine bleeding and blood pressure patterns, patient satisfaction, and continuation rates
Authors:
- R.D. SmithRSR.D. Smith
- B.A. CromerBCB.A. Cromer
- J.R. HayesJHJ.R. Hayes
- R.T. BrownRBR.T. Brown
- 1 January 1995
- journal article
- Published by Elsevier in Adolescent and Pediatric Gynecology
- Vol. 8 (1) , 24-28
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Drug Regulation in the United States and the United Kingdom: The Depo-Provera StoryAnnals of Internal Medicine, 1987
- A COMPREHENSIVE REVIEW OF INJECTABLE CONTRACEPTION WITH SPECIAL EMPHASIS ON DEPOT MEDROXYPROGESTERONE ACETATEMedical Journal of Australia, 1981
- The Effect of Medroxyprogesterone Acetate on Blood PressureInternational Journal of Gynecology & Obstetrics, 1979
- Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: Norethisterone oenanthate and medroxyprogesterone acetateContraception, 1978
- Contraceptive Use—Efficacy Study Utilizing Medroxyprogesterone Acetate Administered As An Intramuscular Injection Once Every 90 DaysFertility and Sterility, 1973